{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_period = \"second_quarter\", filing_year = 2024 and issue_code = \"MED\" sorted by filing_year descending", "rows": [[3183379, "c2ece435-ec2f-43a9-9e7f-3418499b6483", "2T", "FRANCIS EDWARD & CRONIN, INC.", 311314, "USAGAINSTALZHEIMER'S", 2024, "second_quarter", "MED", "Legislation related to the treatment, detection, and prevention of Alzheimer's disease", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2024-05-14T18:21:42-04:00"], [3183957, "1712d342-7198-4f13-95f6-acc3d431d380", "Q2", "BLUEBIRD STRATEGIES", 401105447, "MYRIAD GENETICS, INC.", 2024, "second_quarter", "MED", "Legislation to regulate clinical testing/labs.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-06-03T14:14:18-04:00"], [3183961, "b44a3bde-efc8-4268-9e6c-f0f60a38ca21", "Q2", "BLUEBIRD STRATEGIES", 401105447, "MYOTONIC", 2024, "second_quarter", "MED", "Increasing funding for Myotonic Dystrophy research. Fiscal Year 2025 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-06-03T14:17:46-04:00"], [3184433, "68818057-4a15-4ab5-a506-ddf0ae4cdf57", "Q2", "MCDERMOTT+ LLC", 401103287, "VERILY LIFE SCIENCES LLC", 2024, "second_quarter", "MED", "Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-06-26T10:00:05-04:00"], [3184488, "0e26c757-dcbc-439f-8a17-24f71d88df84", "Q2", "BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER)", 292538, "SONIC HEALTHCARE USA", 2024, "second_quarter", "MED", "Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-06-27T11:16:55-04:00"], [3184629, "c3b7cd3f-b917-4d90-8d52-5be54c745360", "Q2", "AUBURN HEALTH STRATEGIES, LLC", 292697, "AMERICAN PROFICIENCY INSTITUTE", 2024, "second_quarter", "MED", "proficiency testing for clinical laboratories", "SENATE", null, null, 0, 0, "2024-06-29T18:42:32-04:00"], [3184637, "6d6ea527-f824-444c-aced-aa39ad82be04", "Q2", "OCAL LOBBYING GROUP", 401106825, "SAMERA S.A.", 2024, "second_quarter", "MED", "Obtain funding for Tuberculosis monitoring.", null, null, null, 0, 0, "2024-06-30T09:34:34-04:00"], [3184890, "67e8a608-5a36-4b84-abd7-bb73dee5d2c4", "Q2", "AMERICAN COLLEGE OF CLINICAL PHARMACY", 57258, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2024, "second_quarter", "MED", "Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 144981, 0, 0, "2024-07-01T10:54:57-04:00"], [3184980, "7550252e-f145-4a69-b2e5-4880c32a19a8", "Q2", "THE HARRIS FIRM", 68376, "HOLISTIC INDUSTRIES INC.", 2024, "second_quarter", "MED", "Issues pertaining to cannabis CSA scheduling.", "Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE", 50000, null, 0, 0, "2024-07-01T13:05:09-04:00"], [3185005, "4d1e57ce-8cad-44f4-951b-6f4ff76671d3", "Q2", "OLD NORTH STRATEGIES, LLC", 401106174, "EXELA PHARMA SCIENCES, LLC", 2024, "second_quarter", "MED", "supply chain & FDA issues", "HOUSE OF REPRESENTATIVES,SENATE", 108000, null, 0, 0, "2024-07-01T13:18:29-04:00"], [3185073, "d155dca3-4598-46a2-8611-2a3831d1dea9", "Q2", "REPUBLIC CONSULTING, LLC", 401016871, "IQVIA", 2024, "second_quarter", "MED", "Monitor Health Data Policy.", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-07-01T14:44:07-04:00"], [3185151, "1f87ea82-5fb7-4843-aeec-1e3b440e02d5", "Q2", "HELIX, INC.", 401106164, "HELIX, INC.", 2024, "second_quarter", "MED", "Oversight of Lab Developed Tests, express legislative authority.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2024-07-01T16:07:19-04:00"], [3185519, "54d4ada6-16da-46ec-99a8-171e863eb8e8", "Q2", "MAGILL ASSOCIATES, LLC", 401103511, "THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES", 2024, "second_quarter", "MED", "FY 2025 appropriations for the development of a synthetic vaccine", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-02T14:32:35-04:00"], [3185657, "596b20c2-f147-4dc0-a8cb-fa185ca009fc", "Q2", "CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER", 312496, "CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER", 2024, "second_quarter", "MED", "NIH funding, PACT Act, Accelerating Kids Access Act, NIH reform Senate HELP Minority RFI, genomic testing, LDT testing FDA rule, NICHD workforce reform including K12, NIH reform", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office", null, 34865, 0, 0, "2024-07-03T08:15:00-04:00"], [3185727, "7b1215e6-02a9-4fc5-a60a-273a6241e8a0", "Q2", "CAPSTONE NATIONAL PARTNERS", 8214, "ATTERX BIOTHERAPEUTICS", 2024, "second_quarter", "MED", "research funding", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2024-07-03T11:03:49-04:00"], [3185889, "7d8beb32-01c2-45e8-b481-845acf757434", "Q2", "A10 ASSOCIATES, LLC", 401105040, "AESTHETIC MEDICAL PROVIDERS OF NEW HAMPSHIRE", 2024, "second_quarter", "MED", "Issues promoting the interests of professionals providing medical aesthetic services.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2024-07-03T15:20:50-04:00"], [3185970, "84e1babf-73aa-4b6a-a1ac-35313d8f9202", "Q2", "FRANCIS EDWARD & CRONIN, INC.", 311314, "CURE ALZHEIMER'S FUND", 2024, "second_quarter", "MED", "Legislation related to Alzheimer's disease research", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2024-07-04T14:28:59-04:00"], [3186436, "3edb4690-dba8-419b-8ddb-cd46ec98adc6", "Q2", "MASON STREET CONSULTING, LLC", 401105150, "PERIMETER MEDICAL IMAGING", 2024, "second_quarter", "MED", "Advanced Research Projects Agency for Health (ARPA-H).", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-07-07T09:04:53-04:00"], [3186746, "9f3121f9-c225-479f-b5e9-93a8a3b07b2b", "Q2", "IMPACT MANAGEMENT GROUP", 401104137, "ARKANSAS RESEARCH ALLIANCE", 2024, "second_quarter", "MED", "On behalf of client support continued and future funding for clinical research programs in Arkansas", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-07-08T14:13:36-04:00"], [3186819, "68d33089-2f6b-4fef-bd04-9bb46cd06269", "Q2", "IMPACT MANAGEMENT GROUP", 401104137, "CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC.", 2024, "second_quarter", "MED", "Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021", "HOUSE OF REPRESENTATIVES", null, null, 0, 0, "2024-07-08T15:22:41-04:00"], [3186870, "2b62ee29-8300-44e1-a58f-3f21909203c6", "Q2", "THE LIVINGSTON GROUP, LLC", 49635, "INNOVATIVE VACCINE TECHNOLOGIES", 2024, "second_quarter", "MED", "FY2025 appropriations for the development of a synthetic vaccine", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-08T16:31:59-04:00"], [3187041, "41459312-8c34-47d6-84a0-123ca685c05b", "Q2", "WATKINS & EAGER PLLC", 401104403, "NATIONAL FRAGILE X FOUNDATION", 2024, "second_quarter", "MED", "Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2024-07-09T11:13:23-04:00"], [3187273, "200712a1-435c-4b3e-a2ec-ca9e52ddbb7b", "Q2", "RAY C CULVER III", 11468, "ARKANSAS CHILDREN'S HOSPITAL", 2024, "second_quarter", "MED", "Funding for USDA ARS human nutrition research in the FY2025 House and Senate appropriation bills.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-07-09T13:19:59-04:00"], [3187421, "5495c707-fd65-4c53-a7c6-c7b4abc9cffd", "Q2", "GABBERT CONSULTING CO LLC", 401105309, "CHIPPS, CAFFREY AND DUBILIER, P. S. C.", 2024, "second_quarter", "MED", "FDA issues final rule applying medical device rules to laboratory developed tests", "HOUSE OF REPRESENTATIVES", 9000, null, 0, 0, "2024-07-09T15:18:47-04:00"], [3187555, "b37057b3-21b0-4991-a40c-7ec7ff4af929", "Q2", "THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)", 2970, "THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)", 2024, "second_quarter", "MED", "none", null, null, 189000, 0, 0, "2024-07-09T16:53:10-04:00"], [3187867, "93d4b2f3-fa0f-4b2e-84a4-166412364535", "Q2", "FLORIDA STATE UNIVERSITY", 14952, "FLORIDA STATE UNIVERSITY", 2024, "second_quarter", "MED", "FY 2025 Labor HHS Education Appropriations Act - NIH (NINDS)", "HOUSE OF REPRESENTATIVES,SENATE", null, 38000, 0, 0, "2024-07-10T12:45:03-04:00"], [3188095, "554942a4-806c-401e-a6ef-2a49ad101946", "Q2", "UNIVERSITY OF KENTUCKY", 400287372, "UNIVERSITY OF KENTUCKY", 2024, "second_quarter", "MED", "NCI funding for FY24", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 158183, 0, 0, "2024-07-10T14:58:11-04:00"], [3188245, "6ccc0070-9096-43d6-a493-6920c373dd06", "2T", "LOBBYIT.COM", 400487397, "BRAIN ANEURYSM FOUNDATION", 2024, "second_quarter", "MED", "Advocate for the passage of Ellie's Law (H.R. 902, S. 895) Creation of a dedicated Brain Aneurysm Caucus Appropriation Requests", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2024-07-10T16:22:45-04:00"], [3188461, "411f1f28-c832-4290-8eea-ac3341f49fea", "2T", "WILLIAM SCHMIDT", 401107557, "PULMONARY FIBROSIS FOUNDATION", 2024, "second_quarter", "MED", "Funding for the National Institutes of Health Funding for the Congressionally Directed Medical Research Program at the Department of Defense", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 1, "2024-07-11T09:51:29-04:00"], [3189074, "c0626ed5-82c0-4360-b45e-5bac5b3eccdf", "Q2", "THE DLM GROUP", 313794, "GENESIS HEALTH CARE, INC.", 2024, "second_quarter", "MED", "no activity", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-11T16:31:44-04:00"], [3189501, "5a4c14e3-0e2d-4822-8374-39b231d07cc3", "Q2", "HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.", 52925, "HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.", 2024, "second_quarter", "MED", "MED HR 3226/S 1573: Prematurity Research Expansion and Education for Mothers who Deliver Infants Early (PREEMIE) Reauthorization Act of 2023 All Provisions This bill would reauthorize critical federal research, education and care to reduce preterm birth and infant mortality. MED HR 4534/S 2245 - Women and Lung Cancer Research and Preventative Services Act of 2023 All provisions This bill requires a review of women and lung cancer studies, provides for a public education campaign, and more.", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2024-07-12T12:53:01-04:00"], [3189659, "bdc0b9fb-0fa5-4504-bcbe-f8aee0dba04d", "Q2", "COMPASS GOVERNMENT RELATIONS PARTNERS, LLC", 401106533, "COALITION FOR INNOVATIVE LABORATORY TESTING, INC.", 2024, "second_quarter", "MED", "Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA)", null, null, 0, 0, "2024-07-12T14:25:00-04:00"], [3189783, "232226fb-21af-4e12-94b7-b5f230d73dba", "Q2", "BEN BARNES GROUP LP", 5415, "CLENE NANOMEDICINE, INC.", 2024, "second_quarter", "MED", "ALS", "HOUSE OF REPRESENTATIVES,SENATE", 100000, null, 0, 0, "2024-07-12T15:33:09-04:00"], [3189846, "501272ae-38ba-4d88-8310-4c266f185f6e", "Q2", "BEN BARNES GROUP LP", 5415, "HUNTSMAN CORPORATION", 2024, "second_quarter", "MED", "CMS Medicare", "HOUSE OF REPRESENTATIVES,SENATE", 18750, null, 0, 0, "2024-07-12T15:56:34-04:00"], [3190173, "87922a1f-a660-482c-8a6f-40281e17c943", "Q2", "FORBES-TATE", 400976792, "AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION", 2024, "second_quarter", "MED", "Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-13T11:21:05-04:00"], [3190186, "996773a1-53cb-4111-b7e9-1fe78d0201cd", "Q2", "FORBES-TATE", 400976792, "AMGEN USA, INC.", 2024, "second_quarter", "MED", "Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2024-07-13T11:49:40-04:00"], [3190699, "a406bae2-e628-4687-b404-8fedb588aa56", "Q2", "FEDERAL SOLUTIONS, LLC", 311371, "MISSISSIPPI STATE UNIVERSITY", 2024, "second_quarter", "MED", "Labor/HHS/Education Appropriations: Provisions relating to disease research", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-14T13:00:29-04:00"], [3190778, "85346aa1-3c14-4384-bbf0-643a27df37fe", "Q2", "FORBES-TATE", 400976792, "CALIFORNIA LIFE SCIENCES ASSOCIATION", 2024, "second_quarter", "MED", "Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-14T14:10:39-04:00"], [3190837, "c12d9fc2-840f-41f2-994e-091fe10e6026", "Q2", "FORBES-TATE", 400976792, "COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION", 2024, "second_quarter", "MED", "Issues pertaining to government-wide federal regulation of cannabis.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-14T14:58:03-04:00"], [3190957, "cea35ed4-37de-4c4f-88eb-3e3114c0da2b", "Q2", "FORBES-TATE", 400976792, "CSL BEHRING", 2024, "second_quarter", "MED", "Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. - 6465 Preserving Life-saving Access to Specialty Medicines in America Act.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-07-14T15:56:42-04:00"], [3191212, "174feee1-c7cb-45df-be70-011c13714111", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "JOHNS HOPKINS UNIVERSITY", 2024, "second_quarter", "MED", "Presidential management fellowships;\u202fadvised on Francis Scott Key Bridge collapse; advised on fiscal year 2025 appropriations; advised on Medicare reimbursement; advised on Medicare Graduate Medical Education and Childrens Hospital Graduate Medical Education issues; telehealth; Committee on Foreign Investment in the United States; public health; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; advised on Lower Cost, More Transparency Act, H.R. 5378; advised on Antisemitism Awareness Act, H.R. 6090; advised on S.4115/H.R. 7725, the Embracing anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act; advised on Accreditation for College Excellence (ACE) Act, H.R. 3724; advised on Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, H.R. 5933/S.3362; advised on workforce Pell grant issues.", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE", 60000, null, 0, 0, "2024-07-14T23:42:51-04:00"], [3191336, "a38925fd-78f8-4f79-837a-1438a48764ef", "Q2", "PONTIS PARTNERS, LLC", 401107566, "KIDNEY TRANSPLANT COLLABORATIVE", 2024, "second_quarter", "MED", "Enactment of The Living Organ Volunteer Engagement (LOVE) Act", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-15T09:40:52-04:00"], [3191613, "459de23c-31df-4156-b062-481b61d569b9", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "OU MEDICINE, INC.", 2024, "second_quarter", "MED", "Research and development of medical programs in partnership with Department of Health and Human Services and other federal agencies", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-15T11:33:13-04:00"], [3191691, "7ff7c775-cc31-4552-9d7e-c74fbd3f4667", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "HAZELDEN BETTY FORD FOUNDATION", 2024, "second_quarter", "MED", "Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Service members and Veterans.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-15T11:59:46-04:00"], [3192101, "6f115ae8-2ed8-4e6f-9dc7-d51e18f1b730", "Q2", "TIBER CREEK GROUP", 20744, "JAZZ PHARMACEUTICALS", 2024, "second_quarter", "MED", "Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-15T14:06:43-04:00"], [3192275, "ecb879ef-c09e-4837-93e5-e61b81d786b4", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "MMV MEDICINES FOR MALARIA VENTURE", 2024, "second_quarter", "MED", "The purpose was to increase funding for malaria research in the Department of Defense.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-15T14:57:41-04:00"], [3192413, "7d5aebe6-9702-4f08-a0e7-e8d9d18ff115", "Q2", "AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS", 52105, "AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS", 2024, "second_quarter", "MED", "Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP) PRORP is a competitive grant program that funds research pertaining to extremity war injuries to address the most significant gaps for military personnel with orthopaedic injuries.", "HOUSE OF REPRESENTATIVES,SENATE", null, 433848, 0, 0, "2024-07-15T15:46:35-04:00"], [3192510, "54b4f92d-a359-49dc-b3e4-ec011a32b959", "Q2", "SQUIRE PATTON BOGGS", 30906, "ALLIANCE FOR BIOSECURITY", 2024, "second_quarter", "MED", "Preparedness and response as it relates to Biosecurity.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 80000, null, 0, 0, "2024-07-15T16:18:12-04:00"], [3192733, "90316f9e-bfbe-43a7-9067-44d593e0dd03", "Q2", "DQB INTERNATIONAL", 291834, "TEXAS BIOMEDICAL RESEARCH INSTITUTE", 2024, "second_quarter", "MED", "FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-07-15T17:39:05-04:00"], [3192766, "29e25151-6bec-4fe0-b9c4-3c272b8dd755", "Q2", "2359 STRATEGIES", 401106114, "TRAVERE THERAPEUTICS", 2024, "second_quarter", "MED", "Rare kidney disease", "HOUSE OF REPRESENTATIVES,SENATE", 12000, null, 0, 0, "2024-07-15T17:54:19-04:00"], [3192995, "246f7959-9e81-443b-96fc-f4cdcf71d8cd", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "NIRSENSE, LLC (FKA BIONICA LABS)", 2024, "second_quarter", "MED", "Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations and authorization requests.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2024-07-15T21:39:38-04:00"], [3193002, "8ad14392-f5b4-4625-bef6-bc7c0edd84ac", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "SCIPERIO INC.", 2024, "second_quarter", "MED", "Educated key government stakeholders on Sciperio, Inc.s technology and manufacturing capabilities in support of the Department of Defense. Provide support for Defense appropriations requests.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-07-15T21:50:22-04:00"], [3193005, "fb2c0969-65a2-4c5c-97b8-ceacc5d4af74", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "THE GENEVA FOUNDATION", 2024, "second_quarter", "MED", "Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-15T21:52:25-04:00"], [3193008, "d4b5296f-5a54-4da9-af47-7e6fd32662e8", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "THERADAPTIVE, INC.", 2024, "second_quarter", "MED", "Educated key government stakeholders on Theradaptives products applicable to the military and support appropriations requests.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-15T21:58:08-04:00"], [3193024, "9cd797a5-51b0-4857-8e7f-e10b73a06b58", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "MOBERG ANALYTICS, INC.", 2024, "second_quarter", "MED", "Educated key government stakeholders on Mobergs research and development activities in support of US Service members and support Defense appropriations.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-15T22:16:09-04:00"], [3193083, "54f41762-6440-4e9d-b5b3-f6b156a19d08", "Q2", "AMERICAN SOCIETY OF ADDICTION MEDICINE", 401104864, "AMERICAN SOCIETY OF ADDICTION MEDICINE", 2024, "second_quarter", "MED", "Advocated for increased FY25 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY25 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for at least $10.5 billion for HRSA programs in the FY 2025 Labor, Health and Human Services, Education, and Related Agencies appropriations bill. Joined coalition letter opposing any legislation that would bar medical schools from receiving federal funding if they engage in activities such as having a Diversity, Equity and Inclusion (DEI) office and/or provide education on structural or institutional racism. Advocated for passage of H.R. 7050 - the Substance Use Disorder Workforce Act of 2024, with a recommendation that the Senate include additional monetary incentives in the bill for physicians training as addiction specialists. Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Advocated for draft legislation that would provide Medicare coverage for evidence-based residential SUD services. Advocated for various substance use disorder workforce and coverage policy changes, including the SUPPORT for Patients and Communities Reauthorization Act (S. 3393). Advocated for certain annual increases for Medicare office based SUD bundled codes. Advocated for H.R.5163/S. 3193 - Telehealth Response for E-prescribing Addiction Therapy Services Act, which would amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment. Advocated for S. 3145 - the Improving Access to Addiction Medicine Providers Act, legislation that would modernize the SAMHSA's Minority Fellowship Program (MFP) by amending the Public Health Service Act to include the field of addiction medicine in MFP. Suggested additional regulatory changes to SAMHSA related to opioid treatment programs and the provision of methadone for opioid use disorder. Joined a coalition letter urging support of the Medicaid Bump Act of 2024 (H.R. 4892/S. 3921). This legislation would incentivize states to expand coverage of mental health and substance use disorder (MH/SUD) services by providing a corresponding increase in the Federal Medical Assistance Percentage (FMAP) matching rate to 90 percent. Joined a coalition letter requesting clear guidance from the relevant agencies that explicitly states that suspicious order reporting requirements will not be enforced against buprenorphine approved by the Food and Drug Administration (FDA) for OUD until further notice. Joined a coalition letter calling on the Biden Administration to rescind a $75 'cap' per patient per budget year on incentives in contingency management for treating stimulant use disorder. Joined a coalition letter urging the House Appropriations Committee's approval of the full authorized level of tobacco user fees, and that they oppose any efforts to weaken or alter the Food and Drug Administration's authority over tobacco products in the appropriations process. Joined a coalition letter urging the Centers for Medicare and Medicaid Services (CMS) to improve data collection on access to substance use disorder (SUD) treatment and providers, and to use this data to continue to improve access to SUD treatment in both Medicare Advantage (MA) and traditional Medicare. The letter asks CMS to collect data on network adequacy, reimbursement rates and practices, utilization management, cost-sharing, and supplemental benefits. Sent a comment letter to HRSA on its draft program guidance regarding justice-involved individuals reentering the community ASAM noted the exclusion of pre-trial detainees from this guidance and called on HRSA rescind the omission. Sent a comment letter to the Centers for Medicare and Medicaid Services (CMS) regarding a proposed rule to implement 200 new residency/fellowship slots by fiscal year 2026. ASAM called on CMS to work with HRSA to revise the mental health health professional shortage area (HPSA) definition and related criterion to include clinicians that specialize in treating SUD. Joined a coalition letter requesting the Departments of Health and Human Services, Labor, and Treasury finalize the 2023 proposed parity regulations. Joined a coalition letter requesting $40 million for the Employee Security Benefits Administration (EBSA) within the Department of Labor (DOL) in the FY 2025 Labor-Health and Human Services (HHS) appropriations bill to review health plans' parity compliance analyses.", "Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)", null, 40000, 0, 0, "2024-07-16T06:55:29-04:00"], [3193160, "fb33c07d-5ff5-4648-9cf4-62ec65887b3d", "Q2", "IMPACT HEALTH POLICY PARTNERS", 401104696, "ABBOTT LABORATORIES", 2024, "second_quarter", "MED", "Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-16T08:17:23-04:00"], [3193169, "c373ae4e-1f87-41ea-a940-891216885ca2", "Q2", "IMPACT HEALTH POLICY PARTNERS", 401104696, "CHILDREN'S HOSPITAL COLORADO", 2024, "second_quarter", "MED", "Issues related to pediatric research and children's hospital graduate medical education.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-16T08:20:44-04:00"], [3193186, "5b7aee8b-bb27-4f2f-aa00-a475a069214f", "Q2", "FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)", 86196, "INTUITIVE SURGICAL, INC.", 2024, "second_quarter", "MED", "Lobbying related to health care issues.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-16T08:25:54-04:00"], [3193188, "6e1f7b4f-c655-4ab2-b05e-8f138442cae3", "Q2", "IMPACT HEALTH POLICY PARTNERS", 401104696, "HACKENSACK MERIDIAN HEALTH", 2024, "second_quarter", "MED", "Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 40000, null, 0, 0, "2024-07-16T08:26:30-04:00"], [3193550, "dd11e0d4-23c9-4fc3-86e5-b3332ecf469c", "Q2", "MANATT, PHELPS, AND PHILLIPS", 23645, "LOMA LINDA UNIVERSITY MEDICAL CENTER", 2024, "second_quarter", "MED", "Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF", null, 140000, null, 0, 0, "2024-07-16T10:36:35-04:00"], [3193563, "dc4193fc-2bcc-4280-920c-c3c74cf0a6ce", "Q2", "MANATT, PHELPS, AND PHILLIPS", 23645, "MEDISYS HEALTH NETWORK", 2024, "second_quarter", "MED", "Provider Relief and COVID funding and other healthcare issues; Community Project Funding", null, 40000, null, 0, 0, "2024-07-16T10:39:13-04:00"], [3193873, "e7de8c8b-d052-4e49-9b38-35ab12f8bcd5", "Q2", "CONLON PUBLIC STRATEGIES", 306294, "CHESTNUT HEALTH SYSTEMS", 2024, "second_quarter", "MED", "Educate on the work of Chestnut health systems and explore grant opportunities.", "Agency for Healthcare Research & Quality (AHRQ),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)", 10000, null, 0, 0, "2024-07-16T11:53:56-04:00"], [3194160, "c8d75be8-5808-42e6-91fe-479ee8a02829", "Q2", "UNIVERSITY OF MARYLAND, BALTIMORE (UMB)", 401103161, "UNIVERSITY OF MARYLAND, BALTIMORE (UMB)", 2024, "second_quarter", "MED", "NONE", null, null, 10000, 0, 0, "2024-07-16T13:47:51-04:00"], [3194687, "e84a7b91-8c25-4fc3-b57b-a590c69921ce", "2T", "BURRELL INTERNATIONAL GROUP LLC", 401103483, "ARSENAL MEDICAL, INC.", 2024, "second_quarter", "MED", "DoD Appropriation for Research and Development for hemorrhage control", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2024-07-16T16:03:59-04:00"], [3194997, "c74aedb4-1c47-4a4f-a9e1-ad2bdf66eaaa", "Q2", "MICHAEL N. MCCARTY LAW OFFICE PLLC", 401104300, "AMERICAN MEDICAL TECHNOLOGISTS", 2024, "second_quarter", "MED", "Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to \"harmonize\" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2024-07-16T19:26:04-04:00"], [3195072, "0581a558-5258-4744-974c-5d7d1bf495ad", "Q2", "COMMONWEALTH STRATEGIC PARTNERS, LLC", 401103486, "PEOPLE FOR THE ETHICAL TREATMENT OF ANIMALS (PETA)", 2024, "second_quarter", "MED", "Issues related to animal testing and experimentation, specifically H.R. 4757 Cease Animal Research Grants Overseas (CARGO) Act.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-16T20:31:24-04:00"], [3195076, "66db6967-8bf2-42dc-81f3-bea2ba0a481c", "Q2", "COMMONWEALTH STRATEGIC PARTNERS, LLC", 401103486, "AMERICAN ASSOCIATION OF SUICIDOLOGY", 2024, "second_quarter", "MED", "Support policies and research for suicide awareness, training, outreach, and prevention, including but not limited to robust HHS funding and improvements to the 988 program", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-16T20:32:50-04:00"], [3195161, "2b098a7a-4681-4266-93aa-a283e60d4ba5", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "BIONTECH US INC.", 2024, "second_quarter", "MED", "Educated policymakers on BioNTech's federally funded research and development activities.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2024-07-16T22:26:51-04:00"], [3195164, "e825f803-60c6-4528-88f9-df1aff1d2d6f", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "ARMR SYSTEMS INC", 2024, "second_quarter", "MED", "Educated policymakers on ARMR's research and development activities in support of US Service members and Defense appropriations.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-16T22:30:50-04:00"], [3195172, "a5726ec6-e090-4bbe-b9de-17276b8272ec", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "VOCXI HEALTH", 2024, "second_quarter", "MED", "Educated policymakers and key government stakeholders on VOCxi Health research and development activities in support of US Service members and Defense appropriations.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-16T22:35:53-04:00"], [3195175, "1ca08b59-2f5d-4bfc-b56b-a1de12b3d90c", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "LUMEN BIOSCIENCE, INC.", 2024, "second_quarter", "MED", "Educated policymakers and key government stakeholders on Lumens research and development activities in support of US Service members and Defense appropriations.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-16T22:44:09-04:00"], [3195182, "18d0e906-9842-4fd8-aeb6-b2ed0c8e033d", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "THE UNIVERSITY OF TEXAS SYSTEM", 2024, "second_quarter", "MED", "Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities.", "HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2024-07-16T22:58:38-04:00"], [3195344, "3c925461-95af-4d68-9a7c-0997064e0507", "Q2", "IPOLICY SOLUTIONS", 401105127, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2024, "second_quarter", "MED", "No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to \"Medical Devices; Laboratory Developed Tests\"", "HOUSE OF REPRESENTATIVES,SENATE", 70500, null, 0, 0, "2024-07-17T09:50:48-04:00"], [3195361, "507207f0-db7d-4b4b-83d5-c7b7df2b9829", "Q2", "IPOLICY SOLUTIONS", 401105127, "INVITAE INC.", 2024, "second_quarter", "MED", "H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests", "HOUSE OF REPRESENTATIVES,SENATE", 75000, null, 0, 0, "2024-07-17T09:55:21-04:00"], [3195393, "387fadbe-4627-43ae-b92d-8b39b59e99ab", "Q2", "STRATEGIC MARKETING INNOVATIONS", 60550, "PREVENT BIOMETRICS", 2024, "second_quarter", "MED", "Defense appropriations for medical technology", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2024-07-17T10:03:59-04:00"], [3195701, "5abc9883-2ea5-4c10-9e30-74423bfd52aa", "Q2", "SQUIRE PATTON BOGGS", 30906, "LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.", 2024, "second_quarter", "MED", "Funding support for federally qualified health centers; reauthorization of programs", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-17T11:52:12-04:00"], [3195833, "33110e63-52e9-466d-a8a4-853da7012b29", "Q2", "F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES", 18411, "F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES", 2024, "second_quarter", "MED", "H.R. 2369 The Verifying Accurate Leading-edge IVCT Development Act, Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R. 3795 The Diagnostics Testing Preparedness Plan Act, H.R. 3631 The State Stockpile Act, H. R. 5846 Protecting America from Seasonal and Pandemic, Influenza Act of 2023 (the Influenza Act) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA) and H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 FY25 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act", "HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2024-07-17T12:18:20-04:00"], [3196349, "74a1b3ad-29a4-4038-95be-df4651dca167", "Q2", "STANFORD UNIVERSITY", 36492, "STANFORD UNIVERSITY", 2024, "second_quarter", "MED", "HR 2389 Resident Physician Shortage Reduction Act of 2023 Antiviral drug research / Antiviral Drug Discovery Centers", "HOUSE OF REPRESENTATIVES,SENATE", null, 120000, 0, 0, "2024-07-17T14:20:33-04:00"], [3196421, "c571d586-2d69-4a8f-9c82-12522a6d49d1", "Q2", "CAPITOL COUNSEL LLC", 313715, "TEMPUS LABS, INC.", 2024, "second_quarter", "MED", "Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-07-17T14:41:10-04:00"], [3196485, "abe2d2e8-9a41-449a-b150-e0f88a88536a", "Q2", "DREXEL UNIVERSITY", 40032273, "DREXEL UNIVERSITY", 2024, "second_quarter", "MED", "Advocacy around Medicaid reimbursements for high Medicaid medical facilities", "HOUSE OF REPRESENTATIVES,SENATE", null, 90000, 0, 0, "2024-07-17T14:53:17-04:00"], [3196938, "f0bc39c2-08b6-47ea-adac-87c26b8d1084", "Q2", "FONTENOT HEALTH POLICY LLC", 401107703, "ORGANIZE DBA ORGANIZE ACTION NETWORK", 2024, "second_quarter", "MED", "Organ Procurement reforms; Revisions to the Outcme Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486); Organ Procurement Organizations Conditions of Coverage; S. 1688/H.R. 2544 Securing the U.S. Organ Procurement and Transplantation Network Act", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,White House Office", 10000, null, 0, 0, "2024-07-17T16:40:46-04:00"], [3197074, "1d3a0b45-2f0b-4afe-b898-9b24684779e0", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "DEFENSE HEALTH RESEARCH CONSORTIUM", 2024, "second_quarter", "MED", "H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, Defense Health Research Programs", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2024-07-17T17:39:52-04:00"], [3197103, "8eef7401-f7ea-44c1-9df1-3b176ff535ec", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "PANCREATIC CANCER ACTION NETWORK (PANCAN)", 2024, "second_quarter", "MED", "H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, Peer-Reviewed Pancreatic Cancer Research Program; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on pancreatic cancer", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-17T17:46:25-04:00"], [3197107, "2d6d1e43-5303-4003-9ad2-0ad0502c5aef", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "FOUNDATION FOR PERIPHERAL NEUROPATHY", 2024, "second_quarter", "MED", "H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, DoD funding for peripheral neuropathy research; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on peripheral neuropathy", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2024-07-17T17:48:18-04:00"], [3197117, "82b627cf-eb86-4e4f-8100-101e5dba4200", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "TUBEROUS SCLEROSIS ALLIANCE", 2024, "second_quarter", "MED", "H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-07-17T17:54:21-04:00"], [3197120, "5b982d08-78d2-4517-a250-c20099fc6d1f", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "KIDNEYCAN", 2024, "second_quarter", "MED", "H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, kidney cancer research at NIH", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2024-07-17T17:55:35-04:00"], [3197125, "c2b0ea58-c562-42a6-843c-94ddbcf9e3c5", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "VHL ALLIANCE", 2024, "second_quarter", "MED", "H.R. 8774/S. unnumbered, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2024-07-17T17:57:34-04:00"], [3197130, "17581873-8d27-44eb-a685-988955942d53", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "NATIONAL CMV FOUNDATION", 2024, "second_quarter", "MED", "H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, DoD research on congenital CMV; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2024-07-17T17:59:53-04:00"], [3197262, "2e3d3527-2d54-4932-9c3c-3dc5780488ab", "Q2", "COVINGTON & BURLING LLP", 11195, "RWE ALLIANCE INC.", 2024, "second_quarter", "MED", "Real-world health data and analytics policy.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2024-07-17T19:49:24-04:00"], [3198041, "3fd2bcb4-806b-437c-add1-1375230c83d5", "Q2", "COVINGTON & BURLING LLP", 11195, "AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)", 2024, "second_quarter", "MED", "Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation; VALID Act (H.R. 2369)", "HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2024-07-18T10:21:44-04:00"], [3198219, "38d70dbf-4102-4943-8a37-d9d82a474fa3", "Q2", "DA VINCI GROUP", 11548, "KAI MEDICAL LABORATORY", 2024, "second_quarter", "MED", "Funding for Clinical Research & Diagnostics Programs", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2024-07-18T10:49:29-04:00"], [3198243, "24d511a4-36a6-4089-a84a-155a54288b87", "Q2", "MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE)", 400265214, "MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE)", 2024, "second_quarter", "MED", "Supporting funding for NIH, ARPA-H, CDC, HRSA, SAMHSA, ASPR, and DOD medical research.", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 325000, 0, 0, "2024-07-18T10:52:24-04:00"], [3198264, "ac1ebc26-865b-41a9-b177-9d715982b55c", "Q2", "UNIVERSITY OF IOWA", 49191, "UNIVERSITY OF IOWA", 2024, "second_quarter", "MED", "N.A.", "HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2024-07-18T10:53:13-04:00"], [3198476, "dd20268b-b316-4f37-93ca-df90e222861a", "Q2", "MARSHFIELD CLINIC HEALTH SYSTEM", 57830, "MARSHFIELD CLINIC HEALTH SYSTEM", 2024, "second_quarter", "MED", "research support, agriculture, farm safety, child care and agriculture communities", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2024-07-18T11:30:06-04:00"], [3198530, "a5c3b813-5a55-4e57-9852-d3db375a6105", "Q2", "NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH", 26557, "NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH", 2024, "second_quarter", "MED", "Support funding for biomedical research", "HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2024-07-18T11:37:10-04:00"], [3198815, "0a62696f-fbec-4d1a-8d6e-1de5ade6467f", "Q2", "CASE WESTERN RESERVE UNIVERSITY", 8418, "CASE WESTERN RESERVE UNIVERSITY", 2024, "second_quarter", "MED", "FY25 House and Senate Appropriations. East Palestine Health Impact Monitoring Act of 2024 (HR 8537 & S. 4045), NIH Funding, COVID Research, opioid prevention & research, Prion Center, brain health, neurodegeneration research, neuropsychiatry, scope of nursing, nursing research, nursing workforce development programs, telehealth, racial disparities research, social determinants of health, maternal and infant health and mortality, Clinical and Translational Sciences Awards (CTSA), ARPA-H, Cancer Research, Foreign Influence Issues.", "HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2024-07-18T12:40:11-04:00"], [3198912, "0a5a8bea-a3ac-4083-9e00-e5eb6d2f23c3", "Q2", "NATIONAL MULTIPLE SCLEROSIS SOCIETY", 69674, "NATIONAL MULTIPLE SCLEROSIS SOCIETY", 2024, "second_quarter", "MED", "S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation U.S. HOUSE OF REPRESENTATIVES, U.S. Senate, Natl Institutes of Health (NIH), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA)", "Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)", null, 41572, 0, 0, "2024-07-18T12:57:22-04:00"], [3199049, "5679895f-1ec4-4fde-99ca-3b16605520b9", "Q2", "NATIONAL NURSES UNITED", 40021153, "NATIONAL NURSES UNITED", 2024, "second_quarter", "MED", "S.1113 Support for Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act S.1176 Support for The Workplace Violence Prevention for Health Care and Social Service Workers Act S.3744 Support for The Health ACCESS Act S.3860 Support for Nurse Overtime and Patient Safety Act S.4046 Support for VA Employee Fairness Act H.R.2530 Support Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act H.R.2663 Support The Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.3421 Support The Medicare for All Act H.R.4328 Support National Nursing Shortage Task Force Act H.R.9200 Support for The Stop Nurse Shortages Act Support for Medicare for All Oppose HICPAC/CDC infection control draft guidelines and calling for inclusion of labor in working group Oppose CDC planning to shorten isolation timeframes for Covid-19 to less than five days Discuss issues related to AI and the Nursing Workforce Discuss concerns related to VA Privatization and hiring freeze Urge the Department of Labor (DOL) to expeditiously advance the development of an enforceable, permanent infectious diseases standard by the Occupational Safety and Health Administration (OSHA) Urge CDC and HICPAC to protect health care workers and patients from infectious diseases. Support the Biden administration's march-in rights framework to lower prescription drug prices and call for it to be strengthened.", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Occupational Safety & Health Administration (OSHA),Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE,White House Office", null, 100000, 0, 0, "2024-07-18T13:18:32-04:00"], [3199190, "415733fe-966c-4f92-9d0c-c0bf4edef25b", "Q2", "THE JACKSON LABORATORY", 401104723, "THE JACKSON LABORATORY", 2024, "second_quarter", "MED", "Issues related to biomedical research. Animal model use in biomedical research.", "HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE", null, 30000, 0, 0, "2024-07-18T13:37:06-04:00"]], "truncated": false, "filtered_table_rows_count": 315, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_period\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "second_quarter", "p1": "2024", "p2": "MED"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED", "results": [{"value": "MED", "label": "MED", "count": 315, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED", "results": [{"value": 2024, "label": 2024, "count": 315, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&issue_code=MED", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED", "results": [{"value": "second_quarter", "label": "second_quarter", "count": 315, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_year=2024&issue_code=MED", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "filing_type", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED&_facet=filing_type"}, {"name": "income_amount", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED&_facet=income_amount"}, {"name": "is_termination", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED&_facet=is_termination"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED&_facet_date=received_date"}], "next": "2024,3199190", "next_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2024&issue_code=MED&_next=2024%2C3199190&_sort_desc=filing_year", "private": false, "allow_execute_sql": true, "query_ms": 1766.004400094971, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}